EcoDrugPlus

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSPCTG00005006847
Gene Symbol: GRM5
3 Cross references
272 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSPCTG00005006203
Gene Symbol: GSK3A
3 Cross references
260 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSPCTG00005004301
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSPCTG00005005964
Gene Symbol: GUCY1A2
3 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSPCTG00005000407
Gene Symbol: GUCY1B1
1 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSPCTG00005021927
Gene Symbol: HSP90AA1
3 Cross references
204 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSPCTG00005002944
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSPCTG00005022384
Gene Symbol: HRH4
3 Cross references
103 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPCTG00005002404
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSPCTG00005011238
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSPCTG00005016631
Gene Symbol: HDAC5
3 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSPCTG00005006652
Gene Symbol: HDAC6
3 Cross references
183 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).